EHRA Premium Access

New insights in pacing

Event: EHRA 2021
Topic: Antibradycardia Pacing
Session type: Abstract Sessions
Date: 25 April 2021
Time: 17:15 - 18:10

Session

7 presentations in this session

Clinical outcomes with ventricular pacing or dual-chamber pacing for sinus-node dysfunction: a nationwide matched control study.

Speaker: Professor L. Fauchier (Tours, FR)
Thumbnail

Anatomical predictors of high grade atrioventricular conduction disorders in patients with specific pacemaker implanted after TAVI

Speaker: Doctor P. Frey (Annecy, FR)
Thumbnail

Long-term follow-up of heart transplant patients treated with permanent pacemaker: a monocentric study

Speaker: Doctor L. Tua (Pavia, IT)
Thumbnail

How good is operator opinion at predicting high ventricular pacing burden among patients receiving device therapy for bradycardia?

Speaker: Doctor R. Chattopadhyay (Cambridge, GB)
Thumbnail

How many patients treated for bradycardia may be eligible for His bundle pacing?

Speaker: Doctor R. Chattopadhyay (Cambridge, GB)
Thumbnail

Comparison of QRSarea and left ventricular activation time during left bundle branch pacing and left ventricular septal pacing.

Speaker: Mr L. Heckman (Maastricht, NL)
Thumbnail

Direct capture of the left bundle branch compared to left bundle branch area pacing deteriorates interventricular synchrony but improves left ventricular lateral wall depolarization duration

Speaker: Doctor K. Curila (Prague, CZ)
Thumbnail

7 speakers from this session

Professor Laurent Fauchier

Tours Regional University Hospital, Hospital Trousseau, Tours (France)
12 presentations
1 follower

Doctor Pierre Frey

Centre Hospitalier Annecy Genevois, Annecy (France)
0 follower

Doctor Lorenzo Tua

Policlinic Foundation San Matteo IRCCS, Pavia (Italy)
0 follower

Doctor Rahul Chattopadhyay

Cambridge University Hospital NHS Trust, Cambridge (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Rahul Chattopadhyay

Cambridge University Hospital NHS Trust, Cambridge (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Mr Luuk Heckman

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
0 follower

Doctor Karol Curila

Charles University of Prague , Prague (Czechia)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk